Journal: PLoS ONE
Article Title: Effects of miR-103 by negatively regulating SATB2 on proliferation and osteogenic differentiation of human bone marrow mesenchymal stem cells
doi: 10.1371/journal.pone.0232695
Figure Lengend Snippet: (A) Real-time qPCR analysis detected mRNA expression of RUNX2 , BGLAP and SPP1 in HBMScs after treatment with agomiR-103 or agomiR-NC. (B) The RUNX2 , BGLAP and SPP1 mRNA expression were significantly increased in the antagomiR-103 treated HBMScs. (C and D) Western blot analysis of the protein expression of RUNX, BGLAP and SSP1 in HBMScs by miR-103 overexpression and knockdown. (E) The ALP activity of HBMScs was significantly suppressed when miR-103 was overexpressed. (F) The osteogenic differentiation of HBMScs transfected with agomiR-103 and agomiR-NC was observed by Alizarin red S staining. (G) Knockdown of miR-103 exhibited higher ALP activity after osteogenic differentiation of 21 days. (H) Alizarin red S staining investigated the ability of mineralized-bone matrix formation in HBMScs treated with antagomiR-103 or antagomiR-NC. Columns mean of three independent experiments. * p <0.05, *** p <0.001.
Article Snippet: Cells were conventional cultured in OriCell® HBMScs Complete Medium (HUXMA-90011, Cyagen Biosciences) supplemented with 10% of fetal bovine serum, 100 U/ml penicillin and 100 μg/ml streptomycin, and maintained at 37°C in a humidified atmosphere under 5% CO 2 .
Techniques: Expressing, Western Blot, Over Expression, Knockdown, Activity Assay, Transfection, Staining